Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG40444

EDC4 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The EDC4 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting the EDC4 gene in HEK293T cells. EDC4 encodes an enhancer of mRNA decapping that interacts with DCP2 and DCP1A to promote 5'-3' mRNA decay and P-body assembly. This loss-of-function model is ideal for investigating mRNA stability, P-body dynamics, and post-transcriptional gene regulation in a highly transfectable background. Applications include cancer, neurodegeneration, and viral replication studies using assays such as western blotting, RT-qPCR, and P-body immunofluorescence.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    EDC4

    Gene Identifier

    NCBI Gene ID 23644

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The EDC4 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the endogenous EDC4 gene in HEK293T cells. This product provides a mixed population of gene-edited cells, each carrying targeted disruptions in the EDC4 locus, enabling loss-of-function studies without the need for single-cell clonal isolation. The polyclonal format preserves the inherent heterogeneity of the knockout, facilitating robust and reproducible investigations of EDC4-dependent mRNA decay pathways. This model serves as a versatile tool for researchers examining post-transcriptional gene regulation, P-body dynamics, and associated cellular processes.

The HEK293T host cell line is a widely used human embryonic kidney epithelial derivative, originally established by stable transfection of HEK293 cells with adenovirus 5 DNA. These cells constitutively express the SV40 large T-antigen, which supports episomal replication of plasmids containing the SV40 origin of replication, thereby enhancing protein expression from transfected vectors. HEK293T cells are highly transfectable and are extensively employed for recombinant protein production, lentivirus and retrovirus packaging, and gene-editing applications. Their robust growth characteristics and compatibility with a broad range of molecular biology techniques make them an ideal background for generating knockout models to study fundamental eukaryotic processes.

EDC4 (enhancer of mRNA decapping 4) is a core component of the cellular mRNA decapping machinery, functioning as a scaffold that potentiates the catalytic activity of the DCP2 decapping enzyme in complex with DCP1A. Through direct interactions with DCP1A, DCP2, and additional factors such as LSM14A, EDC3, PATL1, and DDX6, EDC4 accelerates 5′-to-3′ mRNA decay and promotes the assembly of processing bodies (P-bodies). Upstream signals??including microRNAs, endoplasmic reticulum stress, and AU-rich element binding proteins??regulate EDC4 activity, directing the degradation of target mRNAs, miRNA target transcripts, and ARE-containing mRNAs. This places EDC4 at the intersection of the 5′-3′ mRNA decay pathway, nonsense-mediated mRNA decay, and miRNA-mediated silencing.

Disruption of EDC4 in HEK293T cells offers a powerful model to dissect the molecular mechanisms governing mRNA turnover and P-body formation. Given the cell line??s high transfectability and permissiveness for reporter assays, this knockout population is particularly suited for analyzing how the loss of EDC4 alters the stability of specific transcripts, the composition and morphology of P-bodies, and the cellular response to stress-induced translational repression. The model enables studies where EDC4??s role can be uncoupled from redundant decay pathways, providing insights relevant to cancer biology, neurodegenerative disorders, and viral infections that subvert host mRNA decay machinery.

This EDC4 knockout polyclonal cell population supports a wide range of experimental approaches. Researchers can employ western blotting to confirm EDC4 depletion, RT-qPCR and actinomycin D chase assays to measure mRNA half-life changes, and RNA-seq for transcriptome-wide decay profiling. Immunofluorescence co-staining for P-body markers such as DDX6 allows visualization of EDC4-dependent P-body dynamics, while luciferase reporter mRNA stability assays provide quantitative readouts of decapping activity. For further information on product specifications and custom inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)